FDA首批新冠床邊檢驗Cepheid試劑45分鐘內可知結果 | 合法醫療器材資訊網

Cepheid has developed an automated molecular test for the qualitative detection of SARS-CoV-2, the virus that causes COVID-19. The test leverages the design ... Read More

Cepheid®, the Cepheid logo, GeneXpert®, and Xpert® are trademarks of Cepheid. ... cases of Coronavirus infectious disease 2019 (COVID-19) worldwide​. Read More

... of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization​ ... Read More

A rapid, near-patient test for the detection of the 2019 novel coronavirus that causes COVID-19. Xpert Xpress SARS-CoV-2/Flu/RSV. Actionable rapid respiratory ... Read More

此一產品是設計使用於該公司的自動化 GeneXpert 系統，檢測時間約需45 分鐘。​全球目前約有23,000 多個自動化GeneXpert 系統，且此自動化系統 ... Read More

2020年3月23日 — ... 批准首項新型冠狀病毒肺炎(COVID-19)的定點照護檢驗試劑(又稱床邊檢驗, ... GeneXpert為一項能同時執行1~80項跨多種領域的檢測項目的檢驗 ... Read More

Cepheid®, the Cepheid logo, GeneXpert® and Xpert® are trademarks of ... collected from individuals suspected of COVID-19 by their healthcare provider. Read More

from individuals who are suspected of COVID-19 infection. Results are for ... Cepheid®, the Cepheid logo, GeneXpert®, and Xpert® are trademarks of Cepheid. Read More